EX
EXAS
EXACT SCIENCES CORP
No data for this timeframe.
Vol
Inst. Holders2 funds
Inst. Value$5.4M
Inst. Activity0 buys / 50 sells
Reddit Sentiment67° Warm
SEC Reports3
Congressional1 trades
Recent Activity
Jun 12, 2026
SEC
26 institutions net purchased $269M of EXAS in Q3, led by Ameriprise (+$214.7M), Schroder (+$28.8M), and Soros (+$16.3M)
INST-CLUSTER — Impact 5/10
Apr 29, 2026
earnings_calendar
EXAS Q1 2026 Earnings After Market Close — 2026-04-29
Apr 2, 2026
SEC
Exact Sciences Corporation is deregistering its securities and terminating its SEC reporting obligations, citing fewer t
15-12G — Impact 7/10
Mar 24, 2026
Congress
Kevin Hern sell
$1,001 - $15,000 — House
Mar 23, 2026
Insider
Conroy Kevin T was granted 119,312 shares
President and CEO
Mar 23, 2026
Insider
Conroy Kevin T disposed of 18,143 shares
President and CEO
Mar 23, 2026
Insider
Condella Sarah disposed of 191,891 shares
EVP, Human Resources
Feb 28, 2026
SEC
Three major institutions—Morgan Stanley, Norges Bank, and RenTech—collectively added $732.4M in new positions in Exact S
INST-CLUSTER — Impact 7/10
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$106.30 (Jan 2026)
Current $104.91
Low $105.00
Median $105.00
High $118.00
10 analysts
$105.00
$118.00
Analyst Ratings
2Strong Buy
6Buy
21Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 20, 2026 | Mizuho | DOWNGRADE | Outperform → Neutral |
| Jan 5, 2026 | Evercore ISI Group | DOWNGRADE | Outperform → In-Line |
| Nov 28, 2025 | Stifel | DOWNGRADE | Buy → Hold |
| Nov 25, 2025 | Canaccord Genuity | DOWNGRADE | Buy → Hold |
| Nov 24, 2025 | Benchmark | DOWNGRADE | Buy → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next Q | $0.28 ▼ -7.7% | $0.28 — $0.28 | 180% YoY | 1 |
| Current Q | $0.05 ▲ +114.3% | $0.05 — $0.05 | 114% YoY | 1 |
| Next FY | $1.90 ▲ +1.1% | $1.90 — $1.90 | 109% YoY | 1 |
| Current FY | $0.91 ▼ -19.8% | $0.91 — $0.91 | 1200% YoY | 1 |
Latest Reports
BULLISH
INST-CLUSTER
5/10
26 institutions net purchased $269M of EXAS in Q3, led by Ameriprise (+$214.7M), Schroder (+$28.8M), and Soros (+$16.3M)
Jun 12, 2026
BEARISH
15-12G
7/10
Exact Sciences Corporation is deregistering its securities and terminating its SEC reporting obligations, citing fewer t
Apr 2, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ExodusPoint Capital Management, LP | $4.2M | EXIT |
| WEALTH ENHANCEMENT ADVISORY SERVICES, | $1.2M | NEAR_EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 23, 2026 | Conroy Kevin | A | $0.00 |
| Mar 23, 2026 | Conroy Kevin | D | $0.00 |
| Mar 23, 2026 | Condella Sarah | D | $0.00 |
| Mar 23, 2026 | Petrovic Shacey | D | $0.00 |
| Mar 23, 2026 | Trigg Leslie | D | $0.00 |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
Congressional Trades
1 members: 0 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Kevin Hern | R | SELL | $1,001 - $15,000 |
2 institutional holders with $5.4M total value (51,081 shares) as of 2026-Q1. Top holders: ExodusPoint, WEALTH. Net selling activity: 50 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ExodusPoint Capital Management, LP | 39,600 | $4.2M | 77.5% | EXIT -100.0% |
| 2 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 11,481 | $1.2M | 22.5% | NEAR_EXIT -87.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | NEAR_EXIT | 93,066 | 11,481 | -87.7% | $1.2M | 2026-Q1 |
| Magnetar Financial LLC | EXIT | 708,272 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Erste Asset Management GmbH | EXIT | 375,000 | 0 | -100.0% | $0.00 | 2026-Q1 |
| ExodusPoint Capital Management, LP | EXIT | 266,329 | 0 | -100.0% | $0.00 | 2026-Q1 |
| PICTON MAHONEY ASSET MANAGEMENT | EXIT | 400,000 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Centiva Capital, LP | EXIT | 180,000 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Capula Management Ltd | EXIT | 413,170 | 0 | -100.0% | $0.00 | 2026-Q1 |
| GABELLI FUNDS LLC | EXIT | 279,230 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Verition Fund Management LLC | EXIT | 1,234,379 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Alberta Investment Management Corp | EXIT | 688,000 | 0 | -100.0% | $0.00 | 2026-Q1 |
| FARALLON CAPITAL MANAGEMENT LLC | EXIT | 6,405,000 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Pentwater Capital Management LP | EXIT | 7,250,000 | 0 | -100.0% | $0.00 | 2026-Q1 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | EXIT | 204,949 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Jain Global LLC | EXIT | 230,716 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Hudson Bay Capital Management LP | EXIT | 1,115,996 | 0 | -100.0% | $0.00 | 2026-Q1 |
| BAMCO INC /NY/ | EXIT | 954,547 | 0 | -100.0% | $0.00 | 2026-Q1 |
| BLAIR WILLIAM & CO/IL | EXIT | 128,517 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Grantham, Mayo, Van Otterloo & Co. LLC | EXIT | 217,755 | 0 | -100.0% | $0.00 | 2026-Q1 |
| LMR Partners LLP | EXIT | 881,340 | 0 | -100.0% | $0.00 | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | EXIT | 1,978,628 | 0 | -100.0% | $0.00 | 2026-Q1 |
| CAPSTONE INVESTMENT ADVISORS, LLC | EXIT | 251,384 | 0 | -100.0% | $0.00 | 2026-Q1 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | EXIT | 138,121 | 0 | -100.0% | $0.00 | 2026-Q1 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | EXIT | 115,000 | 0 | -100.0% | $0.00 | 2026-Q1 |
| Baird Financial Group, Inc. | EXIT | 309,269 | 0 | -100.0% | $0.00 | 2026-Q1 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | EXIT | 1,067,342 | 0 | -100.0% | $0.00 | 2026-Q1 |
14 unique insiders with 41 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Conroy Kevin T | President and CEO | AWARD | 119,312 | — | — |
| Mar 23, 2026 | Conroy Kevin T | President and CEO | D | 18,143 | — | — |
| Mar 23, 2026 | Condella Sarah | EVP, Human Resources | D | 191,891 | — | — |
| Mar 23, 2026 | Petrovic Shacey | Director | D | 16,406 | — | — |
| Mar 23, 2026 | Trigg Leslie | Director | D | 3,244 | — | — |
| Mar 23, 2026 | Barber Michael J | Director | D | 7,422 | — | — |
| Mar 23, 2026 | Clancy Paul J | Director | D | 20,640 | — | — |
| Mar 23, 2026 | Barber Michael J | Director | D | 7,738 | — | — |
| Mar 23, 2026 | Popovits Kimberly J | Director | D | 6,725 | — | — |
| Mar 23, 2026 | Conroy Kevin T | President and CEO | D | 235,388 | — | — |
| Mar 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | D | 6,581 | — | — |
| Mar 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | D | 38,707 | — | — |
| Mar 23, 2026 | Condella Sarah | EVP, Human Resources | D | 21,948 | — | — |
| Mar 23, 2026 | Condella Sarah | EVP, Human Resources | D | 23,224 | — | — |
| Mar 23, 2026 | COWARD D SCOTT | Director | D | 4,175 | — | — |
| Mar 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | D | 153,726 | — | — |
| Mar 23, 2026 | Condella Sarah | EVP, Human Resources | AWARD | 60,389 | — | — |
| Mar 23, 2026 | COWARD D SCOTT | Director | D | 52,164 | — | — |
| Mar 23, 2026 | Conroy Kevin T | President and CEO | D | 1,397,738 | — | — |
| Mar 23, 2026 | ORVILLE JACOB A | EVP, GM, Screening | AWARD | 53,323 | — | — |
| Mar 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | D | 138,679 | — | — |
| Mar 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | 793 | — | — |
| Mar 23, 2026 | Baranick Brian | EVP, GM, Precision Oncology | AWARD | 33,321 | — | — |
| Mar 23, 2026 | Baranick Brian | EVP, GM, Precision Oncology | D | 137,195 | — | — |
| Mar 23, 2026 | Baranick Brian | EVP, GM, Precision Oncology | D | 28,063 | — | — |
| Mar 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | 68,195 | — | — |
| Mar 23, 2026 | Herriott James | SVP, General Counsel & Sec | D | 20,321 | — | — |
| Mar 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | AWARD | 89,911 | — | — |
| Mar 23, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | D | 4,395 | — | — |
| Mar 23, 2026 | Zanotti Katherine S | Director | D | 55,361 | — | — |
| Mar 23, 2026 | Doyle James Edward | Director | D | 52,564 | — | — |
| Feb 27, 2026 | Conroy Kevin T | President and CEO | EXERCISE | 18,143 | — | — |
| Feb 27, 2026 | Condella Sarah | EVP, Human Resources | EXERCISE | 3,900 | $5.03 | $19.6K |
| Feb 27, 2026 | Condella Sarah | EVP, Human Resources | TAX W/H | 1,913 | $103.38 | $197.8K |
| Feb 25, 2026 | Condella Sarah | EVP, Human Resources | AWARD | 23,224 | — | — |
| Feb 25, 2026 | Baranick Brian | EVP, GM, Precision Oncology | AWARD | 28,063 | — | — |
| Feb 25, 2026 | ORVILLE JACOB A | EVP, GM, Screening | AWARD | 38,707 | — | — |
| Feb 25, 2026 | Bloomer Aaron | EVP, Chief Financial Officer | AWARD | 28,063 | — | — |
| Feb 25, 2026 | Conroy Kevin T | President and CEO | AWARD | 13,181 | — | — |
| Feb 25, 2026 | Conroy Kevin T | President and CEO | AWARD | 154,829 | — | — |
| Feb 25, 2026 | Herriott James | SVP, General Counsel & Sec | AWARD | 20,321 | — | — |
3 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 1 mixed, 0 neutral. Avg impact: 6.3/10.
BULLISH
INST-CLUSTER
5/10
26 institutions net purchased $269M of EXAS in Q3, led by Ameriprise (+$214.7M), Schroder (+$28.8M),
Jun 12, 2026
BEARISH
15-12G
7/10
Exact Sciences Corporation is deregistering its securities and terminating its SEC reporting obligat
Apr 2, 2026
MIXED
INST-CLUSTER
7/10
Three major institutions—Morgan Stanley, Norges Bank, and RenTech—collectively added $732.4M in new
Feb 28, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jan 2026): 28% buy across 29 analysts — 2 strong buy, 6 buy, 21 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$106.30 mean target (Jan 2026)
$105.00 Low
$118.00 High
| Metric | Value |
|---|---|
| Current Price | $104.91 |
| Target Low | $105.00 |
| Target Mean | $106.30 |
| Target Median | $105.00 |
| Target High | $118.00 |
| # Analysts | 10 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next Q 2026-06-30 |
$0.28 | $0.28 | $0.28 | 180.3% | -7.7% | 3↑ 0↓ | $0.9B | 13.0% | 1 |
| Current Q 2026-03-31 |
$0.05 | $0.05 | $0.05 | 114.0% | +114.3% | 1↑ 1↓ | $0.8B | 19.1% | 1 |
| Next FY 2027-12-31 |
$1.90 | $1.90 | $1.90 | 108.8% | +1.1% | 1↑ 3↓ | $4.1B | 12.3% | 1 |
| Current FY 2026-12-31 |
$0.91 | $0.91 | $0.91 | 1200.0% | -19.8% | 3↑ 0↓ | $3.7B | 12.7% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.050 | |
| 7d ago | $0.023 | +0.027 |
| 30d ago | $0.023 | +0.027 |
| 60d ago | $0.103 | -0.053 |
| 90d ago | $0.103 | -0.053 |
19 analyst firms have rated this stock: 0 upgrades, 11 downgrades, 3 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 20, 2026 | Mizuho | DOWNGRADE | Outperform | Neutral |
| Jan 5, 2026 | Evercore ISI Group | DOWNGRADE | Outperform | In-Line |
| Nov 28, 2025 | Stifel | DOWNGRADE | Buy | Hold |
| Nov 25, 2025 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| Nov 24, 2025 | Benchmark | DOWNGRADE | Buy | Hold |
| Nov 24, 2025 | Jefferies | DOWNGRADE | Buy | Hold |
| Nov 21, 2025 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Nov 21, 2025 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Nov 21, 2025 | Guggenheim | DOWNGRADE | Buy | Neutral |
| Nov 21, 2025 | Barclays | DOWNGRADE | Overweight | Equal-Weight |
| Nov 20, 2025 | BTIG | DOWNGRADE | Buy | Neutral |
| Nov 11, 2025 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Nov 5, 2025 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Nov 4, 2025 | TD Cowen | MAINTAIN | Buy | Buy |
| Nov 4, 2025 | Baird | MAINTAIN | Outperform | Outperform |
| Nov 4, 2025 | Benchmark | MAINTAIN | Buy | Buy |
| Nov 4, 2025 | Guggenheim | MAINTAIN | Buy | Buy |
| Nov 4, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Nov 4, 2025 | Stifel | MAINTAIN | Buy | Buy |
| Nov 4, 2025 | BTIG | MAINTAIN | Buy | Buy |
| Oct 22, 2025 | BTIG | MAINTAIN | Buy | Buy |
| Oct 8, 2025 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Oct 7, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Oct 2, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Sep 11, 2025 | Craig-Hallum | MAINTAIN | Buy | Buy |
| Aug 12, 2025 | BTIG | MAINTAIN | Buy | Buy |
| Aug 11, 2025 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Aug 8, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Aug 7, 2025 | UBS | MAINTAIN | Neutral | Neutral |
| Aug 7, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Aug 7, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Jul 8, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Jun 24, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| May 2, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| May 2, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| May 2, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| May 2, 2025 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 11, 2025 | Guggenheim | REITERATE | Buy | Buy |
| Apr 10, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 10, 2025 | Mizuho | INITIATE | — | Outperform |
| Mar 13, 2025 | RBC Capital | INITIATE | — | Sector Perform |
| Feb 26, 2025 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Feb 24, 2025 | Scotiabank | MAINTAIN | Sector Outperform | Sector Outperform |
| Feb 20, 2025 | B of A Securities | MAINTAIN | Buy | Buy |
| Feb 20, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 23, 2025 | Barclays | INITIATE | — | Overweight |
| Jan 13, 2025 | Benchmark | REITERATE | Buy | Buy |
| Dec 13, 2024 | B of A Securities | MAINTAIN | Buy | Buy |
| Nov 26, 2024 | TD Cowen | MAINTAIN | Buy | Buy |
| Nov 26, 2024 | BTIG | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| May 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Apr 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Mar 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Feb 1, 2026 | 2 | 6 | 21 | 0 | 0 | 28% | |
| Jan 1, 2026 | 2 | 8 | 19 | 0 | 0 | 34% |
Strong BuyBuyHoldSellStrong Sell
1 members of Congress traded this stock: 0 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | Kevin Hern | R | HOUSE | SELL | $1,001 - $15,000 | Exact Sciences Corporation | Apr 6, 2026 (14d) |
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 2, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 2, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Apr 29, 2026
earnings_calendar
EXAS Q1 2026 Earnings After Market Close — 2026-04-29
Mar 23, 2026
short_interest
FTD: EXAS — 6,494 shares ($0.7M) failed to deliver
Settlement: 20260323, Price: $104.91, FTD Value: $681,285.54, EXACT SCIENCES CORPORATION
Mar 16, 2026
dark_pool
Dark Pool: EXAS — 4.2M shares, 40,329 trades
Week starting 2026-03-16. Total ATS volume: 4,172,137 shares across 40,329 trades.
Mar 9, 2026
dark_pool
Dark Pool: EXAS — 2.4M shares, 36,549 trades
Week starting 2026-03-09. Total ATS volume: 2,377,926 shares across 36,549 trades.
Mar 3, 2026
short_interest
FTD: EXAS — 55,749 shares ($5.8M) failed to deliver
Settlement: 20260303, Price: $103.35, FTD Value: $5,761,659.15, EXACT SCIENCES CORPORATION
Mar 2, 2026
dark_pool
Dark Pool: EXAS — 2.1M shares, 36,477 trades
Week starting 2026-03-02. Total ATS volume: 2,101,926 shares across 36,477 trades.
Feb 23, 2026
dark_pool
Dark Pool: EXAS — 2.6M shares, 37,620 trades
Week starting 2026-02-23. Total ATS volume: 2,575,207 shares across 37,620 trades.
Feb 16, 2026
dark_pool
Dark Pool: EXAS — 1.7M shares, 28,635 trades
Week starting 2026-02-16. Total ATS volume: 1,689,640 shares across 28,635 trades.
Feb 13, 2026
short_interest
FTD: EXAS — 20,470 shares ($2.1M) failed to deliver
Settlement: 20260213, Price: $103.23, FTD Value: $2,113,118.1, EXACT SCIENCES CORPORATION
Feb 9, 2026
dark_pool
Dark Pool: EXAS — 2.0M shares, 29,209 trades
Week starting 2026-02-09. Total ATS volume: 1,983,023 shares across 29,209 trades.
Feb 2, 2026
dark_pool
Dark Pool: EXAS — 2.9M shares, 37,605 trades
Week starting 2026-02-02. Total ATS volume: 2,855,654 shares across 37,605 trades.